1
|
Rossant J and Howard L: Signaling pathways
in vascular development. Annu Rev Cell Dev Biol. 18:541–573. 2002.
View Article : Google Scholar
|
2
|
Alva JA and Iruela-Arispe ML: Notch
signaling in vascular morphogenesis. Curr Opin Hematol. 11:278–283.
2004. View Article : Google Scholar : PubMed/NCBI
|
3
|
Limbourg FP, Takeshita K, Radtke F, et al:
Essential role of endothelial Notch1 in angiogenesis. Circulation.
111:1826–1832. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Krebs LT, Shutter JR, Tanigaki K, et al:
Haploinsufficient lethality and formation of arteriovenous
malformations in Notch pathway mutants. Genes Dev. 18:2469–2473.
2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Duarte A, Hirashima M, Benedito R, et al:
Dosage-sensitive requirement for mouse Dll4 in artery development.
Genes Dev. 18:2474–2478. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Krebs LT, Xue Y, Norton CR, et al: Notch
signaling is essential for vascular morphogenesis in mice. Genes
Dev. 14:1343–1352. 2000.PubMed/NCBI
|
7
|
Uyttendaele H, Ho J, Rossant J and
Kitajewski J: Vascular patterning defects associated with
expression of activated Notch4 in embryonic endothelium. Proc Natl
Acad Sci USA. 98:5643–5648. 2001. View Article : Google Scholar : PubMed/NCBI
|
8
|
Baim SB, Labow MA, Levine AJ and Shenk T:
A chimeric mammalian transactivator based on the lac repressor that
is regulated by temperature and isopropyl
β-D-thiogalactopyranoside. Proc Natl Acad Sci USA. 88:5072–5076.
1991.PubMed/NCBI
|
9
|
Wyborski DL and Short JM: Analysis of
inducers of the E.coli lac repressor system in mammalian
cells and whole animals. Nucleic Acids Res. 19:4647–4653.
1991.PubMed/NCBI
|
10
|
Plück A: Conditional mutagenesis in mice:
the Cre/loxP recombination system. Int J Exp Pathol. 77:269–278.
1996.PubMed/NCBI
|
11
|
Kos CH: Cre/loxP system for generating
tissue-specific knockout mouse models. Nutr Rev. 62:243–246.
2004.PubMed/NCBI
|
12
|
Lewandoski M: Conditional control of gene
expression in the mouse. Nat Rev Genet. 2:743–755. 2001. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lobe CG, Koop KE, Kreppner W, et al: Z/AP,
a double reporter for Cre-mediated recombination. Dev Biol.
208:281–292. 1999. View Article : Google Scholar : PubMed/NCBI
|
14
|
Liu J and Lobe CG: Cre-conditional
expression of constitutively active Notch1 in transgenic mice.
Genesis. 45:259–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gossen M and Bujard H: Tight control of
gene expression in mammalian cells by tetracycline-responsive
promoters. Proc Natl Acad Sci USA. 89:5547–5551. 1992. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gossen M, Freundlieb S, Bender G, et al:
Transcriptional activation by tetracyclines in mammalian cells.
Science. 268:1766–1769. 1995. View Article : Google Scholar : PubMed/NCBI
|
17
|
St-Onge L, Furth PA and Gruss P: Temporal
control of the Cre recombinase in transgenic mice by a tetracycline
responsive promoter. Nucleic Acids Res. 24:3875–3877. 1996.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Novak A, Guo C, Yang W, Nagy A and Lobe
CG: Z/EG, a double reporter transgenic mouse line that expresses
enhanced green fluorescent protein upon Cre-mediated recombination.
genesis. 28:147–155. 2000. View Article : Google Scholar
|
19
|
Schlaeger TM, Bartunkova S, Lawitts JA, et
al: Uniform vascular-endothelial-cell-specific gene expression in
both embryonic and adult transgenic mice. Proc Natl Acad Sci USA.
94:3058–3063. 1997. View Article : Google Scholar : PubMed/NCBI
|
20
|
Guo C, Yang W and Lobe CG: A Cre
recombinase transgene with mosaic, widespread tamoxifen-inducible
action. Genesis. 32:8–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Takakura N, Huang XL, Naruse T, et al:
Critical role of the TIE2 endothelial cell receptor in the
development of definitive hematopoiesis. Immunity. 9:677–686. 1998.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Kisanuki YY, Hammer RE, Miyazaki J, et al:
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage
analysis in vivo. Dev Biol. 230:230–242. 2001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sarao R and Dumont DJ: Conditional
transgene expression in endothelial cells. Transgenic Res.
7:421–427. 1998. View Article : Google Scholar : PubMed/NCBI
|
24
|
Rammos C, Hendgen-Cotta UB, Deenen R, et
al: Age-related vascular gene expression profiling in mice. Mech
Ageing Dev. 135:15–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Stan RV, Tse D, Deharvengt SJ, et al: The
diaphragms of fenestrated endothelia: gatekeepers of vascular
permeability and blood composition. Dev Cell. 23:1203–1218. 2012.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu Y, Carson-Walter EB, Cooper A, et al:
Vascular gene expression patterns are conserved in primary and
metastatic brain tumors. J Neurooncol. 99:13–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
27
|
Steinman RA: Cell cycle regulators and
hematopoiesis. Oncogene. 21:3403–3413. 2002. View Article : Google Scholar : PubMed/NCBI
|
28
|
Smith C: Hematopoietic stem cells and
hematopoiesis. Cancer Control. 10:9–16. 2003.PubMed/NCBI
|
29
|
Tang J, Shao W, Dorak MT, et al: Positive
and negative associations of human leukocyte antigen variants with
the onset and prognosis of adult glioblastoma multiforme. Cancer
Epidemiol Biomarkers Prev. 14:2040–2044. 2005. View Article : Google Scholar : PubMed/NCBI
|
30
|
Dorak MT, Burnett AK and Worwood M: HFE
gene mutations in susceptibility to childhood leukemia: HuGE
review. Genet Med. 7:159–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Brumpt C, Delabesse E, Beldjord K, et al:
The incidence of clonal T-cell receptor rearrangements in B-cell
precursor acute lymphoblastic leukemia varies with age and
genotype. Blood. 96:2254–2261. 2000.PubMed/NCBI
|
32
|
Belteki G, Haigh J, Kabacs N, et al:
Conditional and inducible transgene expression in mice through the
combinatorial use of Cre-mediated recombination and tetracycline
induction. Nucleic Acids Res. 33:e512005. View Article : Google Scholar : PubMed/NCBI
|